Showing items 1361-1385 of 2549 (102 Page(s) Totally)
<< < 50 51 52 53 54 55 56 57 58 59 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-04-28T07:25:38Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Chih-Hung Hsu;Cheng A.-L.;Hsu C.;Yang C.-H.;Lu Y.-S.;Lin C.-C.;Bu C.-F.;Yeh K.-H.; CHIH-HUNG HSU; Cheng A.-L.; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; Yeh K.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:34Z |
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study
|
Lin C.-C.;Chih-Hung Hsu;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:34Z |
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
|
Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:32Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Pu Y.-S.;Cheng A.-L.;Huang K.-H.;Tsai Y.-C.;Huang C.-Y.;CHIH-HUNG HSU;Lin C.-C.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:31Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
CHIH-HUNG HSU;Cheng A.-L.;Hsu W.-L.;Tsai Y.-C.;Hsu C.;Yang C.-H.;Yeh K.-H.;Lin C.-C.; Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2020-04-28T07:25:30Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Lin C.-C.; Lee J.-M.; Chang Y.-L.; CHIH-HUNG HSU; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H.; Cheng J.C.-H.;Lee Y.-C.;Tsai Y.-C.;CHIH-HUNG HSU;Chang Y.-L.;Lee J.-M.;Lin C.-C.;Hsu F.-M.; Hsu F.-M. |
| 臺大學術典藏 |
2020-04-28T07:25:30Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.; CHIH-HUNG HSU; Yu C.-J.; Chang Y.-C.; Hsu C.; Yang C.-H.;Yang P.-C.;Cheng A.-L.;Lin C.-C.;CHIH-HUNG HSU;Yu C.-J.;Chang Y.-C.;Hsu C.;Lin Z.-Z.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-04-28T07:25:28Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Hsu F.-M.;Lee Y.-C.;Lee J.-M.;Chih-Hung Hsu;Lin C.-C.;Tsai Y.-C.;Wu J.-K.;Cheng J.C.-H.; Hsu F.-M.; Lee Y.-C.; Lee J.-M.; CHIH-HUNG HSU; Lin C.-C.; Tsai Y.-C.; Wu J.-K.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:28Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.; CHIH-HUNG HSU; Lin C.-C.;Chih-Hung Hsu;Cheng J.C.;Huang C.-Y.;Tsai Y.-C.;Hsu F.-M.;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:25Z |
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma
|
Huang P.-M.; Lee J.-M.; Hsu F.-M.; Hsu F.-M. ;Lee J.-M. ;Huang P.-M. ;Lin C.-C. ;Chih-Hung Hsu ;Tsai Y.-C. ;Lee Y.-C. ;Chia-Hsien Cheng J.; Lin C.-C.; CHIH-HUNG HSU; Tsai Y.-C.; Lee Y.-C.; Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.;Su W.-C.;Yen C.-J.;Chih-Hung Hsu;Su W.-P.;Yeh K.-H.;Lu Y.-S.;Cheng A.-L.;Huang D.C.-L.;Fritsch H.;Voss F.;Taube T.;Yang J.C.-H.; Lin C.-C.; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU; Su W.-P.; Yeh K.-H.; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Hsu F.-M.; Chang Y.-L.; Hsieh M.-S.; CHIH-HUNG HSU; Wang C.-C.;Cheng J.C.-H.;Tsai C.-L.;Lee J.-M.;Huang P.-M.;Lin C.-C.;Chih-Hung Hsu;Hsieh M.-S.;Chang Y.-L.;Hsu F.-M.; Wang C.-C.; Cheng J.C.-H.; Tsai C.-L.; Lee J.-M.; Huang P.-M.; Lin C.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:18Z |
Systematic review and network meta-analysis: Neoadjuvant chemoradiotherapy for locoregional esophageal cancer
|
Huang T.-C.;Chih-Hung Hsu;Lin C.-C.;Tu Y.-K.; Huang T.-C.; CHIH-HUNG HSU; Lin C.-C.; Tu Y.-K. |
| 臺大學術典藏 |
2020-04-28T07:25:17Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; CHIH-HUNG HSU; Lin C.-C.; Huang T.-C.; Guo J.-C.; Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Cheng J.C.-H.;Wang H.-P.;Yeh K.-H.;Cheng A.-L.;Chih-Hung Hsu |
| 臺大學術典藏 |
2020-04-28T07:25:14Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Tsai Y.-C.; Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Chih-Hung Hsu;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; Lin C.-C.; CHIH-HUNG HSU; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:12Z |
Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma
|
Yang P.-C.;Guo J.-C.;Hsieh M.-S.;Lin C.-C.;Chih-Hung Hsu; Yang P.-C.; Guo J.-C.; Hsieh M.-S.; Lin C.-C.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2020-04-28T07:25:12Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
CHIH-HUNG HSU; Yeh K.-H.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Guo J.-C.; Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Yeh K.-H.;Chih-Hung Hsu;Lee J.-M.; Lee J.-M. |
| 臺大學術典藏 |
2020-04-28T07:25:11Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; Tzen K.-Y.; CHIH-HUNG HSU; Lin C.-C.; Wu Y.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Chih-Hung Hsu |
| 臺大學術典藏 |
2020-04-28T07:25:09Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
Cheng A.-L.; Twelves C.; Bogenrieder T.; Huang D.C.-L.; Strelkowa N.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Shiah H.-S.; Yang J.C.-H.; CHIH-HUNG HSU; Lee J.-H.; de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; De Bono J.;Lin C.-C.;Chen L.-T.;Corral J.;Michalarea V.;Rihawi K.;Ong M.;Lee J.-H.;Chih-Hung Hsu;Yang J.C.-H.;Shiah H.-S.;Yen C.-J.;Anthoney A.;Jove M.;Buschke S.;Fuertig R.;Schmid U.;Goeldner R.-G.;Strelkowa N.;Huang D.C.-L.;Bogenrieder T.;Twelves C.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-28T07:25:08Z |
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors
|
Lee J.-H.; Lee J.-H.;Chen T.W.-W.;Chih-Hung Hsu;Yen Y.-H.;Yang J.C.-H.;Cheng A.-L.;Sasaki S.-I.;Chiu L.Y.;Sugihara M.;Ishizuka T.;Oguma T.;Tajima N.;Lin C.-C.; Chen T.W.-W.; CHIH-HUNG HSU; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C. |
| 臺大學術典藏 |
2020-04-28T07:15:06Z |
Application of empirical mode decomposition in the impact-echo test
|
Lin, C.-C.; Liu, P.-L.; Yeh, P.-L.; PEI-LING LIU |
| 臺大學術典藏 |
2020-04-28T07:12:40Z |
A high performance Doppler interferometer for advanced optical storage systems
|
CHIH-KUNG LEE; Lin, Y. C.; Lee, C. K.; Wu, G. Y.; Teng, C. T.; Wu, W. J.; Lin, C. T.; Hsiao, W. H.; Shih, H. C.; Wang, J. S.; Lin, S. C.; Lin, C. C.; Lee, C. F. |
| 臺大學術典藏 |
2020-04-28T07:12:26Z |
Determination of binding constant and stoichiometry for antibody-antigen interaction with surface plasmon resonance
|
Lin, S.; Lee, A.S.-Y.; Lin, C.-C.; Lee, C.-K.; CHIH-KUNG LEE |
| 臺大學術典藏 |
2020-04-28T07:11:22Z |
Heel pad stiffness in plantar heel pain by shear wave elastography
|
Lin, C.-Y.; Lin, C.-C.; Chou, Y.-C.; Chen, P.-Y.; Wang, C.-L.; CHE-YU LIN |
| 臺大學術典藏 |
2020-04-27T08:45:09Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang Y.;Chia-Hsien Cheng;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Hsu C.-H.;Cheng A.-L.;Pu Y.-S.; Chiang Y.; CHIA-HSIEN CHENG; Huang C.-Y.; Tsai Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S. |
Showing items 1361-1385 of 2549 (102 Page(s) Totally)
<< < 50 51 52 53 54 55 56 57 58 59 > >>
View [10|25|50] records per page
